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Abstract These practice guidelines are recom-
mended by the Asian Society of Cardiovascular
Imaging (ASCI), the sole society in Asia designated
for cardiovascular imaging, to provide a framework
to healthcare providers for suggested essential ele-
ments in cardiac magnetic resonance (CMR) exam-
inations of different disease spectra. The guideline is
composed of recommendations on the general tech-
nique, acquisition of some basic modules, and
protocols on stress tests. The protocols for speciﬁc
diseases are provided in a table format for quick
reference to be easily utilized for everyday clinical
CMR.
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Introduction
As the healthcare system, resource allocation, and
pattern of diseases [1, 2] in Asia are different from
those in Western Society, this practice protocol is
recommended by the Asian Society of Cardiovascular
Imaging (ASCI), the sole society dedicated to
cardiovascular imaging in Asia, to provide a frame
work for the suggested essential elements in cardiac
magnetic resonance (CMR) examinations.
It must be emphasized that this guideline has been
built on previously published guidelines from various
professional societies [3–6], but is customized for
CMR practice in Asia with its unique characteristics
and where thalassemia [7–9] and valvular heart
disease are common. The ultimate decision regarding
the propriety of any speciﬁc procedure must be made
after mutual communication with the referring phy-
sicians; the understanding of individual patient’s
condition; and the availability of resources, knowl-
edge and technology provided by their respective
centers by the responsible individuals participating
and performing the CMR procedures.
The practice protocol starts with recommendations
on the general technique and is followed by tech-
niques on the acquisition of some basic modules.
Recommended practice protocols on stress tests with
separate checklists and monitoring sheets are
provided. Protocols for speciﬁc diseases are summa-
rized in a table format for quick reference.
Guidelines
Recommended practice protocol for CMR
examination
Patient preparation
1. Check for any contraindication for MR exami-
nation, stress study, and contrast administration,
if needed.
2. Obtain informed consent for the MR
examination.
3. Advise patient on fasting before examination.
This is not mandatory, but is advised.
4. Have patient stop intake of caffeine-containing
food and beverages, theophylline or dipyridam-
ole at least 24 h before adenosine study; avoid
beta-blocker and nitrates for dobutamine study.
5. Educate and provide practice to patients on the
breathing instruction.
6. Provide the patient with ear plugs.
7. Prepare the skin of the chest and/or abdomen for
optimal attachment of electrodes for cardiac and
respiratory gating.
8. Position the patient in the best comfortable supine
position. Have the patient place the arms above
the head to decrease wrap artifact. It is acceptable
to put the arms along the side or crossed over the
chest if the patient cannot tolerate arms overhead
for extended periods of time.
Equipment and safety
1. Monitoring equipment (blood pressure, electro-
cardiogram, intercom communication with
patients)
2. Resuscitation facilities :
i. emergency resuscitation policy in place
ii. availability of resuscitation team with med-
ical/nursing staff having ACLS accreditation
iii. logistics for transferring patient to designated
resuscitation area outside scanner
iv. resuscitation trolley with full set of emer-
gency medications and equipment
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123v. external pacer and deﬁbrillator
vi. oxygen supply
vii. beta-blockers, nitrates, and aminophylline at
hand
3. Stress MRI testing.
Detail on safety and equipment needed is listed
in the performance protocol for the adenosine
and dobutamine studies
Recommended practice protocol on basic
modules
See Fig. 1 for a quick reference on the acquisition of
major imaging planes described below.
Left ventricular (LV) structure and function module
All scans are recommended to be performed as
breathhold, multiphase steady state free precession
(SSFP) imaging at the end of the expiratory phase
using all elements on the cardiac coil. All 17
segments of the heart can be covered by a combina-
tion of three short axis and two long axis views (four
chambers and two chambers). Scout imaging—mul-
tistack three plane localizers: transtransaxial, coronal,
sagittal
1. Calibrate for parallel imaging technique, if it is to
be used.
2. Shimming
3. Transaxial (8–10 mm) set of SSFP or fast spin
echo (FSE) images through the chest.
4. Vertical long axis scout cine images
i. The vertical long axis scout cine plane is
prescribed from the axial localizer at the
level of mitral and tricuspid valves.
ii. The slice through the LV apex and centre of
the mitral valve is prescribed.
Mitral valve
LV 2 chamber view
Late contrast 
enhancement
Gadolinium first pass 
perfusion
Horizontal long axis view
Vertical  long axis view Transaxial localizer
Tricuspid valve Aortic valve Pulmonary valve
4 chamber view 3 chamber view
RV 2 chamber view LVOT view RVOT  view
Transaxial  view
Short axis view
Basal short  axis view
Start here
Chambers 
& outflow 
views
LV 2 chamber view
Valves
Fig. 1 A road map for major imaging planes of the cardiac magnetic resonance study
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1235. Horizontal long axis scout cine images.
The horizontal long axis scout cine plane is
prescribed from the end systolic phase of the
vertical long axis scout cine image.
i. Position the slice at the center of the mitral
valve and angulate through the LV apex.
ii. Scroll through the diastolic images to ensure
the left atrium is included and properly
imaged.
6. Short axis cine images.
The short axis cine planes are prescribed from
previously acquired long axis scout cines at
diastole, starting from the mitral valve plane
through the LV apex, covering the whole ventri-
cle perpendicular to the interventricular septum
on horizontal long axis scout cine images.
i. Slice thickness 6–8 mm; no gap
ii. Temporal resolution B45 ms between
phases
iii. Parallel imaging to shorten scanning time
7. Other long axis cine images
i. The four chamber cine plane is prescribed
from the vertical long axis scout cine and
short axis cine images. The cut plane should
pass through the LV apex and centre of mitral
valve on the vertical long axis scout cine
image. On the short axis cine image, angulate
the cut plane so that it passes through the
center of the LV chamber and lower corner of
the RV border sure to avoid bisecting the LV
outﬂow tract in the basal short axis view.
ii. The two chamber cine image is prescribed by
a cut plane that bisects the LV apex and
centre of the mitral valve in the four chamber
view, as well as passing through the mid LV
chamber in the short axis view. The cut plane
needs to be in parallel to the ventricular
septum in both views.
iii. The three chamber cine image is prescribed
by a cut plane parallel to the long axis with
the bisecting mitral valve and apex as well as
the bisecting LV outﬂow tract in basal short
axis view.
iv. The LV outﬂow tract (LVOT) long axis is
obtained in the oblique coronal plane from
the true axial scout images by positioning the
slice through the aortic root and directing it
toward the LV apex.
8. Additional views of cine images.
A contiguous stack of transaxial steady state free
precession cine images from the top of the aortic
arch to the inferior wall of the LV is recom-
mended for congenital heart disease.
Right ventricular (RV) structure and function module
RV short axis views are acquired in a similar fashion
to the LV structure and function module. Use a
transaxial stack of cines covering the RV for best
identiﬁcation of the tricuspid valve plane.
1. Right ventricular two chamber long axis view
i. Obtain the right ventricular two chamber
long axis images from four chamber images
ii. Position the centre ofthe slice inthe middle of
the tricuspid valve and angulate through the
RV apex. Scroll through phases to ensure
the slice passes through the end-systolic and
end-diastolic RV apex of the four chamber
images.
2. Right ventricular outﬂow view (RVOT).
Prescribe by placing the slice through the centre
of main pulmonary artery and the RV apex
through a set of axial images.
3. Right ventricular inﬂow and outﬂow view.
An inﬂow/outﬂow plane of the RV can be
acquired using a three-point plane.
i. Place the ﬁrst point on the tricuspid valve of
the four chamber view.
ii. Place the second point on the RV apex of the
two chamber RV view.
iii. Place the third point on the pulmonary valve
of the RVOT view.
Gadolinium ﬁrst pass perfusion module
1. Use scout imaging as per the LV structure and
function module.
2. Use saturation-recovery imaging with gradient
echo-echo planar imaging (GRE-EPI) hybrid,
GRE, or SSFP readout.
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1233. Use at least three short axis slices per each heart
beat (basal, mid, and apical level of LV). Add
one slice in four chamber (for sepal/lateral
segment ischemia) or two chamber view (for
anterior/inferior segment) if the length of the RR
interval permits.
4. Acquire the apical short axis slice ﬁrst and the
most basal short axis last during the cardiac cycle
to minimize cardiac motion artifacts.
5. Use a slice thickness of 8–10 mm, in-plane
resolution, *\3 mm; twofold acceleration and
temporal resolution\100 ms or shorter.
6. Do a dry run at the end expiration for 5–10
phases to check and correct any position and
phase wrap artifacts.
7. Use the following parameters:
i. Give contrast (0.05–0.1 mmol/kg, 3–7 ml/s)
followed by at least 30 ml saline ﬂush
(5–7 ml/s)
ii. Start breathhold during early phases of con-
trast infusion before contrast reaches the LV
cavity.
iii. Readout for 50–60 heart beats to capture the
contrast wash-in and wash-out through LV
myocardium.
Late gadolinium enhancement (LGE) module
1. Wait for 10 min after administration of cumula-
tive dose of 0.1–0.2 mmol/kg gadolinium. A
shorter delay time may be considered if lower
doses of contrast are used.
2. Use 2D segmented inversion recovery GRE
imaging during the end of the diastolic phase.
3. Prescribe the slices at the identical location,
views, and thicknesses as for cine imaging
(short- and long-axis views).
4. In-plane resolution, *1.4–1.8 mm; adjust acqui-
sition duration to a shorter RR interval in
tachycardia.
5. Set inversion time to null normal myocardium.
6. Adjust the read-out according to heart rate. Every
other heart beat in normal setting of heart rate;
every heart beat in the setting of bradycardia, and
every third heart beat in the setting of tachycardia
or arrhythmia.
T2-weighted imaging
1. Consider using either body coil or functional
surface coil intensity correction algorithms.
2. Use breathhold, pre-contrast segmented FSE
imaging (double inversion recovery).
3. Select slice locations based on the suspected area
of acute edema or inﬂammation on cine images.
4. Use a thick (10–12 mm) slice.
5. Obtain short axis, mid ventricular slices by
multiple breathholds, spoiled gradient echo
sequences with nine echo time (5.6–18 ms) for
T2* measurement for iron detection. Adjust the
TR between the 9 RF (segment) pulses according
to the different TE times.
Valvular ﬂow and shunt assessment module
1. Quantitative ﬂow measurement
i. For the ﬂow velocity and volume, the plane
of measurement should be perpendicular to
the vessel and distal to valve leaﬂet tips of
interest. Adapt velocity encoding to actual
velocity by the lowest velocity without
aliasing, and use the lowest TE possible for
high velocity jet ﬂows.
ii. Speciﬁc plane for phase contrast (PC) ﬂow
acquisition.
For the acquisition of different chamber
views stated below, please refer to the basic
modules on structure and function of LV and
RV in Sections A & B.
(a) Mitral Valve: Plan on the end-systolic
two chamber and four chamber cine
images. The center of the slice is
placed in the middle of the mitral valve
and angulated parallel to the mitral
valve.
(b) Tricuspid Valve: Plan on true four-
chamber and RV two-chamber images
at the end systolic phase. The center of
the slice is placed in the middle of the
tricuspid valve and angulated parallel
to the tricuspid valve.
(c) Aortic Valve: Alignment of the imag-
ing plan for the aortic valve is from the
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123three chamber and LVOT views. The
imaging plane should be positioned just
above the aortic valve, yet just below
the origin of the coronary arteries. The
LVOT view is prescribed perpendicu-
lar to the three chamber view.
(d) Pulmonary Valve: Align the imaging
plane from two orthogonal RVOT
views and place the plane just above
the pulmonary valve. The ﬁrst RVOT
view is prescribed from an oblique
plane through the main PA and RV on a
set of axial images. The second RVOT
plane is prescribed perpendicular to the
ﬁrst RVOT.
(e) Pulmonary Arteries: Main pulmonary
artery (MPA)
Prescribe from sagittal localizer and
obtain a few cine slices parallel to the
MPA. The imaging plane for ﬂow
acquisition should be perpendicular to
the direction of ﬂow to the MPA on
these images. The usual peak velocity is
180 cm/s. The encoding velocity rec-
ommended for the ﬁrst measurement or
for ﬂow measurement is 180 cm/s.
Left pulmonary artery (LPA) and right
pulmonary artery (RPA) Imaging
planes through the LPA and RPA
should be perpendicular to the direction
of ﬂow and proximal to the ﬁrst branch-
ing vessel. In general, these planes are
usually 1–1.5 cm distal to the MPA
bifurcation. The usual velocity for peak
measurement is 60–120 cm/s. The rec-
ommended encoding velocity for the
ﬁrst measurement or for ﬂow measure-
ment is 200 cm/s.
(f) Ascending Aorta: Prescribe the imag-
ing plane from the coronal localizer.
The ﬂow acquisition is performed per-
pendicular to the ﬂow direction of the
ascending aorta, about 1.5–2 cm above
the aortic valve at the pulmonary
bifurcation level. The usual peak veloc-
ity measurement is 100–160 cm/s. The
recommended encoding velocity for the
ﬁrst measurement or for ﬂow measure-
ment is 200 cm/s.
2. Qualitative assessment
i. Use gradient echo or hybrid gradient echo/
echo planar imaging as either is better in
visualizing the severity of regurgitant jets or
turbulence across shunts.
ii. For the morphology and planimetry of valve
oriﬁce, optimize the angle and level with
SSFP in the plane of the valve of interest and
use three contiguous 5 mm-thick high reso-
lution cines transecting the line of the jet and
moving from oriﬁce level to immediately
downstream.
iii. Speciﬁc plane for assessment:
(a) Mitral valve: horizontal and vertical
long axis, LVOT view
(b) Aortic valve: LVOT and coronal view
(c) Tricuspid valve: horizontal long axis
and transaxial view
(d) Pulmonary valve: RV long axis or
RVOT view
Recommended protocol for adenosine stress test
1. Follow the checklist attached and set up accord-
ing to the monitoring sheet for adenosine stress
myocardial perfusion test.
2. Perform LV structure and function module as
listed or alternatively acquire these images at
between stress and rest perfusion to shorten
scanning time.
3. Start continuous adenosine infusion (at least
3 min, preferably 4–6 min continuous infusion
of 140 lg/kg body weight/min) and then
i. Perform the gadolinium ﬁrst pass perfusion
module; update the heart rate in response to
the heart rate increase caused by adenosine.
ii. Gadolinium is injected (0.05–0.1 mmol/kg)
during the last minute of adenosine infusion.
iii. Stop adenosine infusion after imaging for
50–60 heart beats when the gadolinium has
passed through LV myocardium.
iv. Continuous ECG monitoring, oxygen satura-
tion monitoring and repeated BP measured at
baseline, during infusion, and for at least
2 min post-infusion of adenosine (see the
monitoring sheet).
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1234. Rest Perfusion
i. Perform only after at least 10 min washout
period for the gadolinium from stress perfu-
sion imaging.
ii. Repeat perfusion imaging without adenosine
using same dose of gadolinium and at the
same slice location, again update the heart
rate.
iii. Consider skipping if the stress perfusion is
free from artifact. However, additional gad-
olinium may be considered for late gadolin-
ium enhancement imaging (for a cumulative
total dose of 0.1–0.2 mmol/kg).
5. Perform the LGE module after waiting for about
10 min after the last dose of contrast.
Recommended protocol for dobutamine stress test
Low dose dobutamine infusion at 10 lg/kg for
5–10 min is an alternative to look for contractile
reserve only.
1. Follow the attached checklist and set up accord-
ing to the monitoring sheet for dobutamine stress
myocardial perfusion test.
2. FollowbaselineLVstructureandfunctionmodule.
3. Dobutamine continuous infusion:
i. Increase the dobutamine infusion in incre-
ments of 10 lg/kg body weight/minute every
3 min starting at 10 lg/kg body weight/min
until target heart rate [85% 9 (220-age)] is
reached.
ii. Add atropine 0.3 mg in fractional doses up to
2 mg, if heart rate response is poor.
iii. Repeat 3 short axis (basal, mid ventricular,
and distal views) and 3 long axis cine
views during each increment of dobutamine
dosing.
iv. Continuously monitor ECG and oxygen, and
measure BP at baseline, during each stage
and at least 10 min after stress test (see the
monitoring sheet).
v. View cine loops online as they are being
acquired at each stage during real-time or
almost at real-time.
vi. Optimize the temporal resolution at every
dosage as the heart rate increases.
vii. Stop test at detection of any new wall
motion or thickening abnormality; systolic
blood pressure increase [240 mmHg and/
or diastolic blood pressure [120 mmHg;
Blood pressure decrease[20 mmHg below
baseline systolic blood pressure and/or
decrease[40 mmHg from a previous level;
severe chest pain or other intractable
symptoms; complex cardiac arrhythmias
or achievement of peak heart rate.
4. Perform ﬁrst pass perfusion at peak stress with
gadolinium at 0.05–0.075 mmol/kg as described
in the perfusion module, wait for 20 min before
acquisition of rest perfusion.
5. Perform the LGE module after waiting for at
least 10 min after the last dose of gadolinium
injection (at a cumulative dose of 0.1–0.2 mmol/
kg).
Conclusion
The elements of the above practice guidelines
recommended by ASCI are based on the currently
available acquisition technology and knowledge on
speciﬁc diseases. ASCI will continue to observe the
ﬁeld and provide the most up-to-date information to
assist in the delivery of the best patient care
(Table 1).
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Appendix
See Tables 2, 3, 4, 5, 6, and 7.
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123Table 2 Checklist for adenosine stress myocardial test
Pre-procedure Checked
I. Check for contraindication for adenosine stress test
1. Known hypersensitivity to adenosine
2. Known or suspected bronchoconstrictive or bronchospastic disease
3. Heart block more than ﬁrst degree
4. Signiﬁcant sinus bradycardia (resting heart rate\45 bpm)
5. Systemic arterial hypotension (\90 mmHg) or severe arterial hypertension
6. Recent myocardial infarction within 3 days
II. Obtain informed consent
III. Perform pre-procedure 12 leads ECG and review by doctor in charge
IV. Place two angiocatheters intravenously to each arm:
1. One IV 20G in antecubital fossa for contrast
2. One IV 20–22G for adenosine infusion
V. Set up infusion pump for adenosine:
Drugs dosage: adenosine 0.14mg/kg/min
Patient’s body weight (BW) = _________ kg; Adenosine concentration _________mg/ml
0.140 (mg/kg/min) 9 BW (kg)/Adenosine concentration (mg/ml) =
Infusion rate _________ (ml/min) =_________ (ml/h)
Total dose of adenosine to be administrated:
0.14 (mg/kg/min) 9 BW (kg) 9 Infusion time (min) = _________ mg
During-procedure
1. Oxygen 2 l/min per nasal cannula
2. Set BP cuff to manual mode. Place BP cuff opposite arm as med administration.
3. Record baseline vital signs- prior to medication administration
4. Aminophylline 125 mg in 50 ml normal saline IVB over 5–6 min prn chest pain and shortness of breath
5. Start adenosine infusion at am/pm (time). Continue vital sign monitoring as shown
Post procedure
1. Perform post stress ECG and review
2. Record ﬁnal vital signs prior to discharge. Report any patient complaints to doctor in charge
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123Table 3 Patient monitoring during adenosine stress cardiac MR examination
Time after start of 
adenosine infusion
Blood pressure
(mmHg)
Heart rate/min SaO2 reading(%) Symptoms
Baseline
30 secs
2 mins
3.5 mins
6 mins 
(intermediate after scan)
8 mins
10 mins
Before discharge
Please indicate the reason(s) for premature termination:
Persistent or symptomatic AV block
Significant drop in systolic blood pressure
Persistent or symptomatic hypotension
Severe respiratory difficulty
Others________________________
Ref: potential side effects during adenosine infusion
1. Flushing, chest pain, palpitations and breathlessness
2. Transient heart block
3. Transient sinus tachycardia
4. Bronchospasm
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123Table 4 Checklist for dobutamine stress myocardial test
Pre-procedure Checked
I. Check for contraindication for dobutamine stress test
1. Severe systemic arterial hypertension (C220/120 mmHg)
2. Unstable angina
3. High grade aortic stenosis (aortic valve area\1 cm/peak aortic valve gradient[50 mmHg)
4. Uncontrolled or complex cardiac arrhythmias
5. Haemodynamically signiﬁcant hypertrophic obstructive cardiomyopathy
6. Uncontrolled heart failure
7. Myocarditis, endocarditis and pericarditis
8. History of sudden death
9. Aortic dissection/high grade aortic aneurysm
10. Mobile left ventricular or left atrial thrombus
II. Check list for contraindications for atropine
1. Advance heart block
2. Glaucoma
3. Pyloric stenosis
4. Obstructive uropathy
5. Myasthenia gravis
II. Obtain informed consent
III. Perform pre-procedure 12 leads ECG and review by doctor in charge
IV. Place two angiocatheters intravenously to each arm:
1. One IV 20G in antecubital fossa for contrast
2. One IV 20–22G for adenosine infusion
V. Set up infusion pump for dobutamine infusion:
VI. Additional medication to be ready for use in examination room
1. TNG table
2. Metropolol 5 mg/ml
3. Atropine 0.6 ml 9 3 ampules
4. NS ﬂush
During-procedure
1. Oxygen 2 l per nasal cannula
2. Set BP cuff to manual mode. Place BP cuff opposite arm as med administration.
3. Record baseline vital signs- prior to medication administration
4. Record time at the start of dobutmaine infusion. Continue vital sign monitoring whenever change of dosage and prn
Post procedure
1. Perform post stress ECG and review
2. Record total amount of drugs given
3. Record ﬁnal vital signs prior to discharge. Report any patient complaints to doctor in charge
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123Table 5 Patient monitoring during dobutamine stress cardiac MR examination
Target heart rate ________________bpm (220-age x 
85%)
Start Time: ______________  End Time:_________________
Time Drug/dose/rate BP (mmHg) HR (bpm) SaO2 (%) Pain scale  (0-10) Assessment/intervention
Baseline
Dobutamine 50 mg in 50 
ml NS @ 10 mcg/kg/min 
=    _______ml/h
Dobutamine 50 mg in 50 
ml NS @ 20mcg/kg/min 
=    _______ml/h
Dobutamine 50 mg in 50 
ml NS @  30mcg/kg/min 
=    _______ml/h
Dobutamine 50 mg in 50 
ml NS @  40mcg/kg/min 
=    _______ml/h
Dobutamine 50 mg in 50 
ml NS @  
___mcg/kg/min =    
_______ml/h
Total volume of 
Dobutamine 
administrated = ____ml
Atropine 0.3 mg IV 1
st
dose
Atropine 0.3 mg IV 2rd 
dose
Atropine 0.3 mg IV 3
rd
dose
Atropine 0.3 mg IV 4
th
dose
Atropine 0.3 mg IV 5
th
dose
Atropine 0.3 mg IV 6
th
dose
Total dose of atropine 
administrated=___  mg
5 minutes after stress test
10 mintues after stress 
test
Pre-discharge
Other medications at recovery phase:______________________________
Was target HR achieved:  Y/N
Reasons for termination:                                      
More than two sites wall motion abnormality
BP >220/120 mmHg
Arrhythmias           Patient cannot tolerate due to other reasons
BP decrease >20 mmHg systolic below baseline systolic BP or decrease > 40 mmHg form a previous level
Max dose of stress
Target heart rate
Severe chest pain
Int J Cardiovasc Imaging (2010) 26:187–202 199
123Table 6 Adenosine infusion protocol (0.14 mg/kg/min over 6 min) adenosine concentration: 3 mg/ml
Wt
(kg)
Wt
(lbs)
Adenosine (mg/
min)
Adenosine
(ml/h)
Adenosine total
dose
Wt
(kg)
Wt
(lbs)
Adenosine (mg/
min)
Adenosine
(ml/h)
Adenosine total
dose
40 88 5.6 112 34 75 165 10.5 210 63
41 90 5.7 114 34 76 167 10.6 213 64
42 92 5.9 118 35 77 169 10.8 216 65
43 95 6.0 120 36 78 172 10.9 218 66
44 97 6.1 122 37 79 174 11.1 221 66
45 99 6.3 126 38 80 176 11.2 224 67
46 101 6.4 129 39 81 178 11.3 227 68
47 103 6.6 132 39 82 180 11.5 230 69
48 106 6.7 134 40 83 183 11.6 232 70
49 108 6.9 137 41 84 185 11.8 235 71
50 110 7.0 140 42 85 187 11.9 238 71
51 112 7.1 143 43 86 189 12.0 241 72
52 114 7.3 146 44 87 191 12.2 244 73
53 117 7.4 148 45 88 194 12.3 246 74
54 119 7.6 151 45 89 196 12.5 249 75
55 121 7.7 154 46 90 198 12.6 252 76
56 123 7.8 157 47 91 200 12.7 255 76
57 125 8.0 160 48 92 202 12.9 258 77
58 128 8.1 162 49 93 205 13.0 260 78
59 130 8.3 165 50 94 207 13.2 263 79
60 132 8.4 168 50 95 209 13.3 266 80
61 134 8.5 171 51 96 211 13.4 269 81
62 136 8.7 174 52 97 213 13.6 272 81
63 139 8.8 176 53 98 216 13.7 274 82
64 141 9.0 179 54 99 218 13.9 277 83
65 143 9.1 182 55 100 220 14.0 280 84
66 145 9.2 185 55 101 222 14.1 283 85
67 147 9.4 188 56 102 224 14.3 286 86
68 150 9.5 190 57 103 227 14.4 288 87
69 152 9.7 193 58 104 229 14.6 291 87
70 154 9.8 196 59 105 231 14.7 294 88
71 156 19.9 199 60 106 233 14.8 297 89
72 158 10.1 202 60 107 235 15.0 300 90
73 161 10.2 204 61 108 238 15.1 302 91
74 163 10.4 207 62 109 240 15.3 305 92
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123Table 7 Adenosine infusion protocol (0.14 mg/kg/min over 6 min) adenosine concentration: 2 mg/ml
Wt
(kg)
Wt
(lbs)
Adenosine (mg/
min)
Adenosine
(ml/h)
Adenosine total
dose
Wt
(kg)
Wt
(lbs)
Adenosine (mg/
min)
Adenosine
(ml/h)
Adenosine total
dose
40 88 5.6 168 34 75 165 10.5 315 63
41 90 5.7 171 34 76 167 10.6 318 64
42 92 5.9 177 35 77 169 10.8 324 65
43 95 6.0 180 36 78 172 10.9 327 66
44 97 6.1 183 37 79 174 11.1 333 66
45 99 6.3 189 38 80 176 11.2 336 67
46 101 6.4 192 39 81 178 11.3 339 68
47 103 6.6 198 39 82 180 11.5 345 69
48 106 6.7 201 40 83 183 11.6 348 70
49 108 6.9 207 41 84 185 11.8 354 71
50 110 7.0 210 42 85 187 11.9 357 71
51 112 7.1 213 43 86 189 12.0 360 72
52 114 7.3 219 44 87 191 12.2 366 73
53 117 7.4 222 45 88 194 12.3 369 74
54 119 7.6 228 45 89 196 12.5 375 75
55 121 7.7 231 46 90 198 12.6 378 76
56 123 7.8 234 47 91 200 12.7 381 76
57 125 8.0 240 48 92 202 12.9 387 77
58 128 8.1 243 49 93 205 13.0 390 78
59 130 8.3 249 50 94 207 13.2 396 79
60 132 8.4 252 50 95 209 13.3 399 80
61 134 8.5 255 51 96 211 13.4 402 81
62 136 8.7 261 52 97 213 13.6 408 81
63 139 8.8 264 53 98 216 13.7 411 82
64 141 9.0 270 54 99 218 13.9 417 83
65 143 9.1 273 55 100 220 14.0 420 84
66 145 9.2 276 55 101 222 14.1 423 85
67 147 9.4 282 56 102 224 14.3 429 86
68 150 9.5 285 57 103 227 14.4 432 87
69 152 9.7 291 58 104 229 14.6 438 87
70 154 9.8 294 59 105 231 14.7 441 88
71 156 19.9 597 60 106 233 14.8 444 89
72 158 10.1 303 60 107 235 15.0 450 90
73 161 10.2 306 61 108 238 15.1 453 91
74 163 10.4 312 62 109 240 15.3 459 92
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